Last updated: 2026-09-09 04:52:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Cronos Group Inc. (CRON) operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector and is listed on NASDAQ. The stock is currently priced at $3.19, with a market capitalization of $1.20B and a P/E ratio of 17.16. Over the past 52 weeks, its price has ranged from $2.28 to $3.61. This page covers its latest market performance, valuation, price trends and company information.
$1.20B | |
$3.24 | |
$25.10 | |
$1.60 | |
$3.26 | |
912.84K | |
1.18M | |
17.16 | |
$3.61 | |
$2.28 | |
0.52% | |
-- |
Cronos Group Inc. (CRON) last closed at $3.26 as of 2026-09-08 23:31:00, unchanged from the previous close of $3.26.
During the latest regular trading session, CRON traded between $1.60 and $25.10, with a volume of 912.84K shares. The closing price was near the lower end and near the upper end of its 52-week range.
Over the past seven days, Cronos Group Inc. (CRON) moved from $3.39 to $3.19, representing a decline of 6.05% ($0.21).
The stock traded between $3.18 and $3.61 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 1.18 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 68.2%
CRON is currently trading at $3.19, placing it 68.2% of the way from its 52-week low of $2.28 to its 52-week high of $3.61. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
| Industry | MEDICINAL CHEMICALS & BOTANICAL PRODUCTS |
| Employees | 610 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Cronos Group Inc. (CRON) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.